Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
NCT07002723

Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality

Led by Peking University Shenzhen Hospital · Updated on 2025-12-05

96

Participants Needed

1

Research Sites

53 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

1. Eligible patients are randomly divided into experimental and control groups; 2. The experimental group is given esketamine combined with dexmedetomidine,while the control group is given normal saline; 3. The patients' sleep, pain, and cognition are followed up after surgery.

CONDITIONS

Official Title

Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age ≥ 65 years old
  • Undergoing hip fracture surgery with neuraxial anesthesia
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • ASA classification of Class V or higher
  • Contraindications to neuraxial anesthesia such as coagulation dysfunction, thrombocytopenia, neuraxial mass, or puncture site infection
  • Allergies or contraindications to esketamine (including intracranial aneurysms, hyperthyroidism, glaucoma)
  • Allergies or contraindications to dexmedetomidine
  • Severe cardiovascular diseases including sick sinus syndrome, severe sinus bradycardia (heart rate < 50 beats/min), atrioventricular block grade II or above without pacemaker, unstable angina, severe valvular heart disease, severe arrhythmia, severe macrovascular disease with NYHA class III
  • Obstructive sleep apnea syndrome with STOP-BANG score over 3
  • Severe liver or kidney failure (Child-Pugh score III, creatinine clearance < 35 mL/min, preoperative dialysis)
  • Pre-existing delirium, dementia, moderate to severe cognitive dysfunction, or psychiatric disorders preventing communication and cooperation with investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China

Actively Recruiting

Loading map...

Research Team

T

Tao Luo, MD,PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here